🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 117 of 151

  1. Scemblix 40 mg film-coated tablets

    Novartis Pharmaceuticals

    CML-CP or CML-AP patients with T315I mutation

    phase 2 small molecule active

    1 trial

  2. Scemblix 40 mg film-coated tablets, Scemblix 40 mg film-coated tablets, Scemblix 20 mg film-coated tablets, Scemblix 40 mg film-coated tablets, NILOTINIB, NILOTINIB, Scemblix 20 mg film-coated tablets, IMATINIB, IMATINIB

    Novartis Pharmaceuticals

    Chronic Myelogenous Leukemia in chronic phase (CML-CP), previously treated with imatinib and have not achieved deep molecular response

    phase 2 small molecule active

    1 trial

  3. Seasonal flu vaccine

    Novartis Pharmaceuticals

    Seasonal Influenza

    phase 2 mab completed

    1 trial

  4. Seasonal influenza vaccine

    Barinthus Biotherapeutics plc.

    Influenza

    phase 2 small molecule terminated

    1 trial

  5. SelG1

    BRIGHT MINDS BIOSCIENCES INC.

    Sickle Cell Disease

    phase 2 small molecule completed

    1 trial

  6. Selatogrel

    Viatris Pharmaceuticals Co.,

    Stable Coronary Artery Disease

    phase 2 small molecule completed

    1 trial

  7. Selegiline

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    3 trials

  8. Selegiline

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    1 trial

  9. Selegiline

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    phase 2 small molecule completed

    1 trial

  10. Selegiline Transdermal Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial

  11. Selegiline hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Abuse

    phase 2 small molecule completed

    1 trial

  12. Self-hypnotic Relaxation

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 other completed

    1 trial

  13. Selinexor

    Karyopharm Therapeutics Inc

    Ovarian Carcinoma

    phase 2 small molecule completed

    1 trial

  14. Selinexor

    Karyopharm Therapeutics Inc

    Non-small Cell Lung Cancer

    phase 2 small molecule terminated

    1 trial

  15. Selinexor

    Karyopharm Therapeutics Inc

    Peripheral T-cell Lymphoma (PTCL)

    phase 2 small molecule terminated

    1 trial

  16. Selinexor

    Karyopharm Therapeutics Inc

    Primary Myelofibrosis

    phase 2 small molecule terminated

    1 trial

  17. Selinexor

    Karyopharm Therapeutics Inc

    Prostate Cancer

    phase 2 small molecule terminated

    1 trial

  18. Selinexor

    Karyopharm Therapeutics Inc

    Recurrent Small Cell Lung Carcinoma

    phase 2 small molecule terminated

    1 trial

  19. Selinexor

    Karyopharm Therapeutics Inc

    Relapse Multiple Myeloma

    phase 2 small molecule active

    1 trial

  20. Selinexor

    Karyopharm Therapeutics Inc

    Myeloma Multiple

    phase 2 small molecule terminated

    1 trial

  21. Selinexor

    Karyopharm Therapeutics Inc

    Myelodysplastic Syndrome

    phase 2 small molecule terminated

    1 trial

  22. Selinexor

    Karyopharm Therapeutics Inc

    Relapsed and Refractory Multiple Myeloma

    phase 2 small molecule active

    1 trial

  23. Selinexor

    Karyopharm Therapeutics Inc

    Multiple Myeloma, Refractory

    phase 2 small molecule active

    1 trial

  24. Selinexor

    Hospital Authority, Hong Kong

    Acute Myeloid Leukemia, Adult

    phase 2 small molecule terminated

    1 trial

  25. Selinexor

    Karyopharm Therapeutics Inc

    Multiple Myeloma in Relapse

    phase 2 small molecule active

    1 trial

  26. Selinexor

    Karyopharm Therapeutics Inc

    Metastatic Colorectal Cancer

    phase 2 small molecule terminated

    1 trial

  27. Selinexor

    Karyopharm Therapeutics Inc

    Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    phase 2 small molecule terminated

    1 trial

  28. Selinexor

    Karyopharm Therapeutics Inc

    Locally Advanced Unresectable or Metastatic Melanoma

    phase 2 small molecule terminated

    1 trial

  29. Selinexor

    Karyopharm Therapeutics Inc

    Smoldering Multiple Myeloma

    phase 2 small molecule active

    1 trial

  30. Selinexor

    Karyopharm Therapeutics Inc

    Solid Tumor Malignancy

    phase 2 small molecule terminated

    1 trial

  31. Selinexor

    Karyopharm Therapeutics Inc

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  32. Selinexor

    Karyopharm Therapeutics Inc

    Acute Myeloid Leukemia (AML)

    phase 2 small molecule completed

    3 trials

  33. Selinexor

    Karyopharm Therapeutics Inc

    Acute Myeloid Leukemia (Relapsed/Refractory)

    phase 2 small molecule completed

    1 trial

  34. Selinexor

    Karyopharm Therapeutics Inc

    Thymoma

    phase 2 small molecule active

    1 trial

  35. Selinexor

    Karyopharm Therapeutics Inc

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  36. Selinexor

    Karyopharm Therapeutics Inc

    Carcinoma, Neuroendocrine

    phase 2 small molecule completed

    1 trial

  37. Selinexor

    Karyopharm Therapeutics Inc

    Coronavirus Infection

    phase 2 small molecule completed

    2 trials

  38. Selinexor

    Karyopharm Therapeutics Inc

    Diabetic Foot Ulcers

    phase 2 small molecule terminated

    1 trial

  39. Selinexor

    Karyopharm Therapeutics Inc

    Myelofibrosis

    phase 2 small molecule active

    2 trials

  40. Selinexor

    Karyopharm Therapeutics Inc

    Diffuse Large B-cell Lymphoma

    phase 2 small molecule active

    1 trial

  41. Selinexor

    Karyopharm Therapeutics Inc

    Glioblastoma

    phase 2 small molecule terminated

    1 trial

  42. Selinexor

    Karyopharm Therapeutics Inc

    Glioblastoma Multiforme

    phase 2 small molecule terminated

    1 trial

  43. Selinexor

    Karyopharm Therapeutics Inc

    Leukemia

    phase 2 small molecule completed

    2 trials

  44. Selinexor

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia (Relapsed/Refractory)

    phase 2 small molecule active

    1 trial

  45. Selinexor (KPT-330)

    Karyopharm Therapeutics Inc

    Squamous Cell Carcinoma

    phase 2 small molecule terminated

    1 trial

  46. Selinexor 100 mg

    Karyopharm Therapeutics Inc

    Non-Small Cell Lung Carcinoma (NSCLC)

    phase 2 small molecule completed

    1 trial

  47. Selinexor 20 MG Oral Tablet

    Karyopharm Therapeutics Inc

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

  48. Selinexor 60 MG

    Karyopharm Therapeutics Inc

    Multiple Myeloma

    phase 2 small molecule on hold

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.